Dr. Cohen Discusses NK-Directed Therapy in Head and Neck Cancer

Ezra Cohen, MD
Published: Tuesday, Jul 25, 2017



Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses natural killer (NK)-directed therapy in head and neck cancer.

Cohen says that NK cell-directed therapies can manipulate NKs ex vivo and then reinfuse them, or even create NKs from regular stem cells from the blood or skin.
 


Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses natural killer (NK)-directed therapy in head and neck cancer.

Cohen says that NK cell-directed therapies can manipulate NKs ex vivo and then reinfuse them, or even create NKs from regular stem cells from the blood or skin.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x